Martin Levinsohn
Partner, Member of the Swedish Bar AssociationPractice areas:
Industries:
Office:
Assistant:
Profile
I work with intellectual property law and competition law, often for clients in the life sciences sector.
I have great experience of representing clients in disputes relating to patents and trademarks, in court and arbitral proceedings and with public authorities. In my daily work, I also help companies with issues relating to licences, research and development collaboration, public procurement and competition law and regulatory issues. I am used to managing and coordinating complex projects with international links.
Språk: English, Swedish, Swedish
Karriär
2002-
Setterwalls
2000-2001
McGill University
2002
Lund University, LL.M.
Rekommendationer
Case
Case | 22 Dec 2025
Setterwalls has successfully represented Sandoz in a patent dispute regarding Xarelto® (rivaroxaban) in Sweden
Case | 03 Mar 2025
Setterwalls advised in connection with the Swedish Competition Authority’s investigation of suspected coordination of price levels on generic drugs
Case | 11 Nov 2022
Setterwalls has successfully represented two pharmaceutical companies in defence against claims for preliminary injunctions
Case | 26 Mar 2021
Setterwalls successfully represented Abboxia vs. the Medical Products Agency
Case | 13 Aug 2020
Setterwalls assisted Isofol when entering into a licensing agreement with Solasia
Case | 28 May 2020
The Court of Justice of the European Union confirms the reasoning that lead to Sandoz’ win in the Patent and Market Court of Appeal
Case | 02 Apr 2020
Setterwalls successfully represented Orifarm Generics in patent dispute
Case | 10 Feb 2020
Setterwalls has successfully represented Sandoz in a patent dispute in the Patent and Market Court.
Case | 31 Jan 2020
Setterwalls successfully acted for Teva in patent dispute at the Patent and Market Court of Appeal
Case | 09 Sep 2019
Parallel traders must rebox medicinal products bearing an anti-tampering device
Case | 20 Mar 2019
Setterwalls successfully represented Europrofil in dispute concerning alleged patent infringement
Case | 01 Feb 2019
Setterwalls successfully represented Sandoz in dispute over supplementary protection certificate for medicinal products
Case | 25 May 2018
Setterwalls acted for Teva in relation to revocation of pharmaceutical patent
Case | 07 Oct 2015
Setterwalls assisted KLS Ugglarps in the acquisition of the majority shares in Dalsjöfors Kött
Artiklar
News | 22 May 2026
Sweden’s application of the IPI measure in relation to Chinese medical devices: almost one year on
Läs nyhet
News | 13 Mar 2026
UPC Court of Appeal Refers Key Questions on Cross-Border Injunctions to CJEU
Läs nyhet
News | 09 Sep 2024
The Swedish and Danish Competition Authorities have carried out dawn raids at companies active in the pharmaceutical sector
Läs nyhet
News | 06 Sep 2023
Third time’s the charm? Setterwalls has once again successfully represented pharmaceutical companies in defending itself against preliminary injunctions
Läs nyhet
News | 09 Mar 2023
Setterwalls has successfully represented a client in a case of invalidation of a patent on sleep medicine
Läs nyhet
News | 10 Jan 2023
Publication UPC: The Sedona Conference Framework for Analysis for the Efficient Resolution of Disputes before the Forthcoming European Unified Patent Court
Läs nyhet
News | 20 Jan 2022
UP/UPC Update: The UPC Agreement may enter into force already in the autumn of 2022
Läs nyhet
News | 22 Sep 2021
ICLG: Patent Law and Regulations 2022. Setterwalls’ experts explain Swedish patent law in the latest edition.
Läs nyhet
News | 14 Jul 2021
UP/UPC Update: Preliminary injunctions against the German UPCA ratification bill rejected – one step closer to the UPC
Läs nyhet
News | 24 May 2021
New Swedish ruling shows that strict liability (still) applies for losses caused by a preliminary injunction
Läs nyhet
News | 07 May 2021
"Launch at risk” does not exclude a right to indemnification for losses suffered from a preliminary injunction
Läs nyhet
News | 23 Mar 2021
AI: turning yesterday’s science fiction into today’s reality – a challenge to the intellectual property rights framework?
Läs nyhet
News | 04 Jan 2021
UP/UPC Update: Two constitutional complaints filed against the German UPCA ratification bill
Läs nyhet
News | 30 Nov 2020
UP/UPC Update: The German Bundestag approves ratification bill for the UPCA
Läs nyhet
News | 24 Sep 2020
Setterwalls' experts explain patent litigation law in Sweden in this years’ edition of ICLG: Patents 2021
Läs nyhet
News | 18 Sep 2020
UP/UPC Update: The UPC Preparatory Committee signals a functional UPC in a near future
Läs nyhet
News | 22 Jun 2020
UP/UPC Update: Germany presents new draft ratification bill for the UPCA
Läs nyhet
News | 30 Mar 2020
UP/UPC Update: The German government signals continued support and preparations for the Unitary Patent System
Läs nyhet
News | 27 Mar 2020
Clinical trials during a pandemic – COVID-19 and its impact on clinical trials
Läs nyhet
News | 24 May 2019
UP/UPC Update: Premises of the Paris seat of the Court of First Instance are displayed
Läs nyhet
News | 23 Aug 2018
Setterwalls' experts explain the basics of litigating and commercializing patents in Sweden
Läs nyhet
News | 22 May 2018
Striking a fair balance between indication patents and skinny-labelled drugs
Läs nyhet
News | 21 Nov 2017
Are you personally liable for your company’s IP infringement? – the Swedish Patent and Market Court rules on IP infringement and lifting the corporate veil
Läs nyhet
News | 17 May 2017
The Swedish Supreme Court takes a stance in the calculation of damages for a wrongful preliminary injunction
Läs nyhet


